33612196 31868830 32078355 33469774 35291732 34889691 35497489 34116814 34080546 34635170 34238629 33602226 - Search Results

Year	Number of Results
2020	4
2021	8
2022	3
2023	0

1

Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder.

Stringer KL, Langdon KJ, McKenzie M, Brockmann B, Marotta P. Stringer KL, et al. J Subst Abuse Treat. 2021 Apr;123:108263. doi: 10.1016/j.jsat.2020.108263. Epub 2020 Dec 26. J Subst Abuse Treat. 2021. PMID: 33612196 Free PMC article.

2

Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service.

Englander H, King C, Nicolaidis C, Collins D, Patten A, Gregg J, Korthuis PT. Englander H, et al. J Addict Med. 2020 Sep/Oct;14(5):415-422. doi: 10.1097/ADM.0000000000000611. J Addict Med. 2020. PMID: 31868830 Free PMC article.

3

Retention of Patients With Multiple Vulnerabilities in a Federally Qualified Health Center Buprenorphine Program: Pennsylvania, 2017-2018.

Weinstein LC, Iqbal Q, Cunningham A, Debates R, Landistratis G, Doggett P, Silverio A. Weinstein LC, et al. Am J Public Health. 2020 Apr;110(4):580-586. doi: 10.2105/AJPH.2019.305525. Epub 2020 Feb 20. Am J Public Health. 2020. PMID: 32078355 Free PMC article.

4

A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study.

Kapadia SN, Griffin JL, Waldman J, Ziebarth NR, Schackman BR, Behrends CN. Kapadia SN, et al. J Gen Intern Med. 2021 Jul;36(7):1898-1905. doi: 10.1007/s11606-020-06409-6. Epub 2021 Jan 19. J Gen Intern Med. 2021. PMID: 33469774 Free PMC article.

5

Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.

Madras BK, Ahmad NJ, Wen J, Sharfstein JS. Madras BK, et al. NAM Perspect. 2020 Apr 27;2020:10.31478/202004b. doi: 10.31478/202004b. eCollection 2020. NAM Perspect. 2020. PMID: 35291732 Free PMC article. Review.

6

The Experience of Implementing a Low-Threshold Buprenorphine Treatment Program in a Non-Urban Medical Practice.

Kapadia SN, Griffin JL, Waldman J, Ziebarth NR, Schackman BR, Behrends CN. Kapadia SN, et al. Subst Use Misuse. 2022;57(2):308-315. doi: 10.1080/10826084.2021.2012484. Epub 2021 Dec 10. Subst Use Misuse. 2022. PMID: 34889691 Free PMC article.

7

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program.

Ward KM, Scheim A, Wang J, Cocchiaro B, Singley K, Roth AM. Ward KM, et al. Drug Alcohol Depend Rep. 2022 Jun;3:100055. doi: 10.1016/j.dadr.2022.100055. Epub 2022 Apr 26. Drug Alcohol Depend Rep. 2022. PMID: 35497489 Free PMC article.

8

Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care.

Chen J, Cabudol M, Williams EC, Merrill JO, Tsui JI, Klein JW. Chen J, et al. J Subst Abuse Treat. 2021 Jul;126:108463. doi: 10.1016/j.jsat.2021.108463. Epub 2021 May 7. J Subst Abuse Treat. 2021. PMID: 34116814

9

Increased utilization of buprenorphine and methadone in 2018 compared to 2015 among Seattle-area persons who inject drugs.

Poorman E, Glick SN, Hiser JKD, Bhatraju E, Tsui JI. Poorman E, et al. J Subst Abuse Treat. 2021 Oct;129:108375. doi: 10.1016/j.jsat.2021.108375. Epub 2021 Mar 19. J Subst Abuse Treat. 2021. PMID: 34080546 Free PMC article.

10

The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.

Frost MC, Lampert H, Tsui JI, Iles-Shih MD, Williams EC. Frost MC, et al. Addict Sci Clin Pract. 2021 Oct 11;16(1):62. doi: 10.1186/s13722-021-00266-2. Addict Sci Clin Pract. 2021. PMID: 34635170 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results